Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

696 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Active, Not Recruiting

Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

NCT04797000

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Novartis Investigative Site Narita, Chiba, Japan
  • Novartis Investigative Site Kurume, Fukuoka, Japan
  • Novartis Investigative Site Ohtake, Hiroshima, Japan
  • Novartis Investigative Site Nishinomiya, Hyōgo, Japan
View all 20 locations
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

NCT05469737

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +5 more
Locations
  • Local Institution - 0137 Miami, Florida, United States
  • Local Institution - 0147 Tamarac, Florida, United States
  • Local Institution - 0132 East Syracuse, New York, United States
  • Local Institution - 0073 Pittsburgh, Pennsylvania, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
View all 32 locations
View Trial Details

Related conditions